VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NHC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
NHCNational HealthCare Corporation
$206.54$3.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksNHCCash Flow

National HealthCare Corporation (NHC) Cash Flow Statement

30Y historyFree accessUpdated daily

Free cash flow generation remains highly inconsistent, with margins swinging from a 14.8% peak in 2025Q3 to 1.7% in 2025Q4, largely driven by volatile working capital changes.

NHC Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Cash from Operations208.36M185.08M107.3M111.22M8.74M62.39M203.26M100.1M98.44M94.47M90.88M73.96M75.69M102.35M64.69M80.65M62.4M85.15M56.88M45.94M35.73M63.84M20.3M45.41M48.56M34.78M52.23M33.59M28.5M35.2M52M
Operating CF Margin %-12.25%8.27%9.74%0.81%6.17%20.73%10.05%10.04%9.8%9.84%8.16%8.68%12.97%8.5%10.43%8.66%12.74%8.98%7.68%6.35%11.77%3.89%9.6%10.6%8.28%11.3%7.63%6.46%7.59%13.46%
Operating CF Growth %436.81%72.48%-3.52%1172.2%-85.99%-69.3%103.05%1.69%4.2%3.94%22.88%-2.29%-26.04%58.21%-19.79%29.24%-26.71%49.7%23.83%28.57%-44.03%214.56%-55.3%-6.5%39.62%-33.41%55.5%17.87%-19.03%-32.31%30.33%
Net Income123.67M122.61M102.09M65.29M19.98M139.09M41.99M67.98M58.7M55.68M50.54M53.14M53.37M64.61M57.96M64.07M52.7M40.05M36.37M45.45M36.74M28.64M23.97M19.95M16.44M13.2M10.22M8.38M-6.4M37M29.3M
Depreciation & Amortization45.56M44.92M41.98M42.03M40.49M40.67M42.02M42.42M41.89M42.65M39.02M37.11M34.38M28.55M29.79M28.9M27.14M25.43M24.82M6.54M12.71M14.15M12.44M11.21M11.15M11.87M14.44M10.38M12.1M14.9M13.2M
Stock-Based Compensation3.37M4.4M4.16M2.78M2.61M2.62M2.45M1.88M1.78M1.68M509K1.98M2.02M2.3M2.37M2.75M321K1.13M2.15M000000000000
Deferred Taxes5.12M6.48M17.94M5.77M6M-6.29M-10.59M4.05M718K-4.71M4.79M-648K-1.43M-2.4M558K1.99M3.5M1.38M-4.49M10.69M-1.72M-2.32M-1.16M-3.49M-1.84M-720K-712K3.53M-10.5M-4.5M0
Other Non-Cash Items-20.15M-26.72M-33.15M-22.05M13.37M-72.95M16.99M-20.17M-653K5.89M6.57M6.68M9.46M1.02M-6.48M2.83M-4.73M-2.58M-3.25M-8.56M-5.86M3.21M2.22M158K6.63M1.23M5.42M2.2M200K100K1.7M
Working Capital Changes48.28M33.4M-25.72M17.4M-73.7M-40.74M110.4M3.95M-4M-6.72M-10.55M-24.3M-22.11M8.28M-19.5M-19.89M-16.53M19.74M1.28M8.47M-384K20.16M-17.18M17.58M16.2M9.2M22.86M9.1M29.5M-13.9M7.8M
Change in Receivables4M-3.68M-26.44M-8.56M-3.86M4.09M4.53M4.3M-9.4M-9.49M-4.4M-11.84M-5.21M-13.78M-7.26M5.03M-15.82M15.97M18.35M000000000000
Change in Inventory-1.07M1.24M-599K-298K1.49M199K-1.25M29K-317K355K60K-441K19K-486K759K434K-372K-251K-488K-103K-754K-364K-218K-319K-379K-51K718K-803K-300K-400K-500K
Change in Payables-275K-2.73M6.3M2.24M-5.53M-2.08M1.43M-856K3.47M-2.62M-1.53M4.25M2.83M2.5M831K-1.11M-352K-2.9M391K000000000000
Cash from Investing-40.75M-33.86M-236.69M-17.57M-5.98M-65.89M-63.88M-14.27M-33.66M-9.56M-81.48M-63.85M-57.51M-56.3M-31.23M-31.75M-46.35M-39.19M-11.12M-118.95M-42.27M-20.04M-8.57M-17.43M3.05M4.21M-50.85M-32.96M-24.9M-51.7M-64.4M
Capital Expenditures-39.95M-36.45M-27.6M-27.9M-30.2M-39.4M-21.87M-26.4M-29.77M-32.35M-62.6M-58.42M-53.3M-43.44M-22M-23.6M-32.84M-44.06M-42.66M-17.76M-37.4M-18.41M-22.74M-24.43M-12.82M-5.34M-6.72M-22M-24M-34.8M-70M
CapEx % of Revenue2.62%2.41%2.13%2.44%2.81%3.9%2.23%2.65%3.04%3.36%6.78%6.44%6.11%5.51%2.89%3.05%4.56%6.59%6.74%2.97%6.64%3.39%4.36%5.17%2.8%1.27%1.45%5%5.44%7.51%18.12%
Acquisitions-3.53M-5.63M-228.1M-7.36M0-29.06M-203K-15.81M3.33M-246K-1.28M-674K-1.98M-21M-7.5M-7.5M-14.34M384K1.19M-91.07M2.79M1.42M000000000
Investments-------------------------------
Other Investing505K512K2.09M-201K8.05M8.84M2.06M-4.08M1.55M4.08M-3.62M8.21M11.14M19.9M47.32M11.33M48.98M25.83M31.52M-21.92M-4.67M318K22.36M6.52M2.19M2.32M-36.88M7.04M3.4M-17.5M18.3M
Cash from Financing-177.44M-135.96M100.34M-42.55M-47.64M-35.26M-41.89M-79.75M-77.27M-49.07M-27.13M-41.67M-30.12M-31.04M-27.77M-16.38M-26.6M-55.98M890K24.71M-3.65M-23.53M-15.02M-34.56M-24.88M-6.81M4.58M-9.21M-8.2M31.8M9.5M
Debt Issued (Net)-134M-97M136.14M-4.99M-4.7M-4.42M-14.17M-48.92M-48.7M-23.48M-3.28M106.91M-2.44M00-95K21K-50.3M42.63M-2.69M-2.45M-2.26M-3.82M-6.72M-25.33M-8.88M8.41M-8.89M-3.6M38.2M22.7M
Equity Issued (Net)-4.13M-516K766K-2.17M-7.79M2.6M1.7M1.47M2M2.52M2.58M-119.9M434K-3.71M13.41M8.39M-3.29M15.39M6.66M5.98M5.67M1.43M3.02M909K1.41M4.64M-2.92M734K1M2.3M1.4M
Dividends Paid-39.23M-38.7M-36.96M-35.56M-34.6M-32.03M-31.92M-31.21M-29.83M-28.24M-25.8M-30.07M-27.37M-26.14M-39.52M-24.62M-23.45M-22.18M-19.88M-9.77M-8.11M0000000-5.4M-21M-17.5M
Share Repurchases-29.33M-14.73M-13.5M-2.48M-9.9M-836K-53K-872K-867K0-8.2M-130.54M-7M-4.7M00-5.94M0000-6.72M-4.38M-258K00-3.31M0000
Other Financing-92K265K402K169K-554K-1.42M2.5M-1.09M-749K120K-635K1.39M-748K-1.2M-1.67M-52K124K1.11M-28.52M31.2M1.24M-15.98M-14.22M-28.75M-955K-2.56M-919K-1.05M-200K12.3M2.9M
Net Change in Cash-9.79M15.27M-29.05M51.1M-44.88M-38.76M97.49M6.09M-12.5M35.83M-17.73M-31.56M-11.94M15M5.69M32.53M-10.54M-10.01M46.65M-48.3M-10.19M20.27M-3.3M-6.59M26.73M32.19M5.96M-8.58M-8.2M31.8M9.5M
Free Cash Flow168.41M148.63M79.7M83.31M-21.46M23M181.39M73.7M68.66M62.12M28.28M15.55M22.4M58.91M42.69M57.06M29.57M41.09M14.22M28.17M-1.67M45.43M-2.45M20.98M35.74M29.44M45.51M11.59M4.5M400K-18M
FCF Margin %11.05%9.84%6.14%7.3%-2%2.27%18.5%7.4%7%6.44%3.06%1.71%2.57%7.47%5.61%7.38%4.1%6.15%2.25%4.71%-0.3%8.38%-0.47%4.44%7.8%7.01%9.84%2.63%1.02%0.09%-4.66%
FCF Growth %85.87%86.48%-4.34%488.27%-193.32%-87.32%146.1%7.34%10.53%119.65%81.91%-30.58%-61.98%37.99%-25.18%92.98%-28.04%188.91%-49.52%1784.93%-103.68%1957.36%-111.66%-41.3%21.42%-35.32%292.74%157.51%1025%102.22%-271.43%
FCF per Share10.689.505.115.42-1.391.4911.804.804.514.081.861.071.573.532.573.482.163.031.082.17-0.133.55-0.201.742.992.523.971.010.400.04-1.82
FCF Conversion (FCF/Net Income)1.36x1.54x1.05x1.66x0.39x0.45x4.85x1.47x1.67x1.68x1.80x1.39x1.42x1.58x1.09x1.24x1.18x2.13x1.56x1.01x0.97x2.23x0.85x2.28x2.95x2.64x5.11x4.01x-4.45x0.95x1.77x
Interest Paid003.42M290K493K845K1.43M3.12M4.9M5.18M4.53M2.96M2.24M497K383K501K658K869K0000000000000
Taxes Paid0017.52M14.57M8.77M22.88M16.52M20.89M9.18M23.55M27.67M29.18M36.64M34.27M34.14M40.8M22.97M21.59M0000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityStrained
Balance SheetFortress
Cash FlowMixed
Top Statement Risk

Working capital volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Earnings Quality Masked by Volatility

Based on reported financial statements, NHC's OCF/NI ratio has fluctuated wildly, reaching a high of 2.65 in 2025Q2 before dropping to 0.68 in 2025Q4, which suggests that net income is an unreliable proxy for the company's actual ability to generate cash from core operations.

The significant variance between net income and operating cash flow indicates that non-cash items and timing differences in revenue recognition are heavily influencing reported results. Investors should monitor whether this decoupling reflects persistent issues in billing cycles or the impact of lumpy incentive payments that distort quarterly performance.

FCF Margin Subject to Swings

As indicated by recent quarterly data, NHC's free cash flow margin has exhibited extreme volatility, ranging from a low of 1.2% in 2024Q1 to a peak of 14.8% in 2025Q3, highlighting a lack of consistent cash generation despite the company's stable operational footprint.

This erratic FCF trajectory suggests that the company's cash flow is highly sensitive to working capital fluctuations rather than steady operational growth. The inability to maintain a consistent FCF margin may imply that the business model is susceptible to sudden shifts in reimbursement timing or unexpected spikes in operating expenses.

Working Capital Drives Cash Swings

According to the cash flow statements, working capital changes have been a primary driver of liquidity, with a $29.9M inflow in 2025Q3 contrasting sharply with a $32.7M outflow in 2024Q4, suggesting that the company's cash position is heavily dependent on the timing of collections and payables.

The frequent and large swings in working capital indicate that NHC's cash flow is not purely reflective of operational efficiency but is instead subject to the inherent complexities of multi-payer billing. This volatility warrants further investigation into whether the company is experiencing delays in receiving government reimbursements or if internal management of accounts receivable is becoming less predictable.

Conservative Capital Allocation Strategy

Based on the provided figures, NHC consistently utilizes cash for dividends and modest share repurchases, with dividend payments remaining steady at approximately $9.9M per quarter throughout 2025, reflecting a commitment to shareholder returns despite the underlying volatility in operational cash flow generation.

The company's disciplined approach to capital deployment suggests that management prioritizes dividend stability over aggressive reinvestment or large-scale acquisitions. While this provides a cushion for shareholders, it also raises questions about whether the company is missing opportunities to deploy capital into higher-growth areas of the healthcare continuum.

NHC — Frequently Asked Questions

Quick answers to the most common questions about buying NHC stock.

How much cash does National HealthCare Corporation (NHC) generate from operations?

National HealthCare Corporation (NHC) generated $185.1M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is National HealthCare Corporation's free cash flow?

National HealthCare Corporation (NHC) generated $148.6M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is National HealthCare Corporation's capital expenditure (CapEx)?

National HealthCare Corporation (NHC) spent $36.4M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does National HealthCare Corporation distribute cash to shareholders?

In 2025, National HealthCare Corporation (NHC) returned $38.7M to shareholders via cash dividends and spent $14.7M on share repurchases. This shows the company's commitment to returning capital to its equity investors.